A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-small-cell lung cancer (Q37921490)

From Wikidata
Jump to navigation Jump to search
scientific article published on 08 September 2011
edit
Language Label Description Also known as
English
A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-small-cell lung cancer
scientific article published on 08 September 2011

    Statements

    A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-small-cell lung cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit